Eurofins CDMO provides integrated, end-to-end drug development solutions supporting clients from the earliest phases of API research and development through finished products.
With 20+ years of experience and 13 global facilities, Eurofins CDMO delivers tailored solutions for complex products, specializing in difficult-to-formulate and innovative formulations.